Risk definition and management strategies in retinoblastoma: current perspectives

References

• ShieldsJAShieldsCLManagement and prognosis of retinoblastomaShieldsJAShieldsCLIntraocular Tumors. A Text and AtlasPhiladelphiaWB Saunders1992377392
   Google Scholar
• ShieldsJAShieldsCLRetinoblastomaShieldsJAShieldsCLAtlas of Intraocular TumorsPhiladelphiaLippincott Williams Wilkins2008293365
   Google Scholar
• MacCarthyADraperGJSteliarova-FoucherEKingstonJERetinoblastoma incidence and survival in European children (1978–1997). Report from the automated childhood cancer information system projectEur J Cancer200642132092210216919773
   PubMed Web of Science ®Google Scholar
• CaveneeWKDryjaTPPhillipsRAExpression of recessive alleles by chromosomal mechanisms in retinoblastomaNature198330559377797846633649
   PubMed Web of Science ®Google Scholar
• ShieldsCLMeadowsATLeaheyAMShieldsJAContinuing challenges in the management of retinoblastoma with chemotherapyRetina200424684986215579981
   PubMed Web of Science ®Google Scholar
• TemmingPCorsonTWLohmannDRRetinoblastoma tumorigenesis: genetic and epigenetic changes walk hand in handFuture Oncol20128552552822646767
   PubMed Web of Science ®Google Scholar
• LohmannDRGallieBLRetinoblastoma: revisiting the model prototype of inherited cancerAm J Med Genet C Semin Med Genet2004129232815264269
   PubMed Web of Science ®Google Scholar
• RichterSVandezandeKChenNSensitive and efficient detection of RB1 gene mutations enhances care for families with retinoblastomaAm J Hum Genet20037225326912541220
   PubMed Web of Science ®Google Scholar
• SimpsonJLCarsonSACisnerosPPreimplantation genetic diagnosis (PGD) for heritable neoplasiaJ Natl Cancer Inst Monogr200534879015784832
   PubMedGoogle Scholar
• BosalehASamporCSolernouVOutcome of children with retinoblastoma and isolated choroidal invasionArch Ophthalmol2012130672472922801832
   PubMedGoogle Scholar
• ChantadaGLCascoFFandiñoACOutcome of patients with retinoblastoma and postlaminar optic nerve invasionOphthalmology2007114112083208917459482
   PubMed Web of Science ®Google Scholar
• ChantadaGLde DavilaMTFandinoARetinoblastoma with low risk for extraocular relapseOphthalmic Genet199920313314010520234
   PubMedGoogle Scholar
• ChantadaGLDunkelIJde DávilaMTAbramsonDHRetinoblastoma patients with high risk ocular pathological features: who needs adjuvant therapy?Br J Ophthalmol20048881069107315258027
   PubMed Web of Science ®Google Scholar
• HungerfordJFactors influencing metastasis in retinoblastomaBr J Ophthalmol19937795418218046
   PubMed Web of Science ®Google Scholar
• SinghADShieldsCLShieldsJAPrognostic factors in retinoblastomaJ Pediatr Ophthalmol Strabismus200037313414110845413
   PubMed Web of Science ®Google Scholar
• KivelaTTrilateral retinoblastoma: a meta-analysis of hereditary retinoblastoma associated with primary ectopic intracranial retinoblastomaJ Clin Oncol19991761829183710561222
   PubMed Web of Science ®Google Scholar
• ShieldsCLShieldsJARecent developments in the management of retinoblastomaJ Pediatr Ophthalmol Strabismus19993618189972509
   PubMed Web of Science ®Google Scholar
• RiesLAGSmithMAGurneyJGCancer Incidence and Survival Among Children and Adolescents: United States SEER Program 1975–1995Bethesda, MDNational Cancer Institute, SEER Program19997378 NIH publication: 99–4649
   Google Scholar
• de SutterEHaversWHoppingWAlbertiWThe prognosis of retinoblastoma in terms of survival, II: a computer assisted studyOphthalmic Paediatr Genet19878285883658342
   PubMed Web of Science ®Google Scholar
• AbramsonDHNiksarliKEllsworthRMServodidioCAChanging trends in the management of retinoblastoma: 1951–1965 vs 1966–1980J Pediatr Ophthalmol Strabismus199431132378195960
   PubMed Web of Science ®Google Scholar
• HonavarSGSinghADShieldsCLPostenucleation adjuvant therapy in high-risk retinoblastomaArch Ophthalmol2002120792393112096963
   PubMedGoogle Scholar
• GündüzKKöseKKurtRARetinoblastoma in Turkey: results from a tertiary care center in AnkaraJ Pediatr Ophthalmol Strabismus201350529630323937863
   PubMed Web of Science ®Google Scholar
• AliMJHonavarSGReddyVADistant metastatic retinoblastoma without central nervous system involvementIndian J Ophthalmol201361735735923548316
   PubMed Web of Science ®Google Scholar
• FingerPTHarbourJWKarciogluZARisk factors for metastasis in retinoblastomaSurv Ophthalmol200247111611801265
   PubMed Web of Science ®Google Scholar
• EagleRCJrHigh-risk features and tumor differentiation in retinoblastoma: a retrospective histopathologic studyArch Pathol Lab Med200913381203120919653710
   PubMed Web of Science ®Google Scholar
• KalikiSShieldsCLRojanapornDHigh-risk retinoblastoma based on international classification of retinoblastoma: analysis of 519 enucleated eyesOpthalmology201312039971003
   Web of Science ®Google Scholar
• KopelmanJEMcLeanIWRosenbergSHMultivariate analysis of risk factors for metastasis in retinoblastoma treated by enucleationOphthalmology19879443713773587919
   PubMed Web of Science ®Google Scholar
• McLeanIWRosenbergSHMessmerEPPrognostic factors in cases of retinoblastoma: analysis of 974 patients from Germany and the United States treated by enucleationBornfeldNGragoudasESHoppingWTumors of the EyeAmsterdam, NetherlandsKugler19916972
   Google Scholar
• SuryawanshiPRamadwarMDikshitRA study of pathologic risk factors in postchemoreduced, enucleated specimens of advanced retinoblastomas in a developing countryArch Pathol Lab Med201113581017102321809993
   PubMed Web of Science ®Google Scholar
• ChantadaGLDunkelIJAntoneliCBRisk factors for extraocular relapse following enucleation after failure of chemoreduction in retinoblastomaPediatr Blood Cancer200749325626017029248
   PubMed Web of Science ®Google Scholar
• ChongEMCoffeeREChintagumpalaMHurwitzRLHurwitzMYChévez-BarriosPExtensively necrotic retinoblastoma is associated with high-risk prognostic factorsArch Pathol Lab Med2006130111669167217076529
   PubMed Web of Science ®Google Scholar
• KarciogluZAParson BamgboyeERetinoblastoma angiogenesis and prognosisExp Eye Res199663S69
   Google Scholar
• ShieldsCLShieldsJABaezKCaterJRDe PotterPOptic nerve invasion of retinoblastoma. Metastatic potential and clinical risk factorsCancer19947336926988299091
   PubMed Web of Science ®Google Scholar
• KashyapSMeelRPushkerNClinical predictors of high risk histopathology in retinoblastomaPediatr Blood Cancer201258335636121721113
   PubMed Web of Science ®Google Scholar
• DerKinderenDJKotenJWVan RomundeLKEarly diagnosis of bilateral retinoblastoma reduces death and blindnessInt J Cancer198944135392744895
   PubMed Web of Science ®Google Scholar
• HaikBGSiedleckiAEllsworthRMSturgis-BuckhoutLDocumented delays in the diagnosis of retinoblastomaAnn Ophthalmol198517117317324083666
   PubMedGoogle Scholar
• ShieldsJAShieldsCLSuvarnamaniCSchroederRPDePotterPRetinoblastoma manifesting as orbital cellulitisAm J Ophthalmol199111244424491928248
   PubMed Web of Science ®Google Scholar
• StaffordWRYanoffMParnellBLRetinoblastomas initially misdiagnosed as primary ocular inflammationsArch Ophthalmol19698267717735307800
   PubMedGoogle Scholar
• RobertsonDMCampbellRJAnalysis of misdiagnosed retinoblastoma in a series of 726 enucleated eyesMod Probl Ophthalmol197718156159876046
   PubMedGoogle Scholar
• MessmerEPHeinrichTHöppingWde SutterEHaversWSauerweinWRisk factors for metastases in patients with retinoblastomaOphthalmology19919821361412008269
   PubMed Web of Science ®Google Scholar
• TemmingPViehmannABiewaldELohmannDRSporadic unilateral retinoblastoma or first sign of bilateral disease?Br J Ophthalmol201397447548023355526
   PubMed Web of Science ®Google Scholar
• ChantadaGLGonzalezAFandinoASome clinical findings at presentation can predict high-risk pathology features in unilateral retinoblastomaJ Pediatr Hematol Oncol200931532532919415010
   PubMed Web of Science ®Google Scholar
• KalikiSShieldsCLShahSUEagleRCJrShieldsJALeaheyAPostenucleation adjuvant chemotherapy with vincristine, etoposide, and carboplatin for the treatment of high-risk retinoblastomaArch Ophthalmol2011129111422142722084213
   PubMedGoogle Scholar
• AbramsonDHEllsworthRMKitchinFDTungGSecond non-ocular tumors in retinoblastoma survivors: are they radiationinduced?Ophthalmology19849111135113556595610
   PubMed Web of Science ®Google Scholar
• LeveneMCongenital retinoblastoma and sarcoma botryoides of the vagina: report of a caseCancer19601353253714416145
   PubMed Web of Science ®Google Scholar
• ReeseABMerriamGRMartinHETreatment of bilateral retinoblastoma by irradiation and surgery. Report on 15-year resultsAm J Ophthalmol194932217519018111333
   PubMed Web of Science ®Google Scholar
• SagermanRHCassadyJRTretterPEllsworthRMRadiation induced neoplasia following external beam therapy for children with retinoblastomaAm J Roentgenol19691053529535
   Web of Science ®Google Scholar
• FletcherOEastonDAndersonKGilhamCJayMPetoJLifetime risks of common cancers among retinoblastoma survivorsJ Natl Cancer Inst200496535736314996857
   PubMedGoogle Scholar
• KleinermanRATuckerMATaroneRERisk of new cancers after radiotherapy in long-term survivors of retinoblastoma: an extended follow-upJ Clin Oncol200523102272227915800318
   PubMed Web of Science ®Google Scholar
• MollACImhofSMBouterLMSecond primary tumors in patients with hereditary retinoblastoma: a register-based follow-up study, 1945–1994Int J Cancer19966745155198759610
   PubMed Web of Science ®Google Scholar
• AcquavivaACiccolalloLRondelliRMortality from second tumour among long-term survivors of retinoblastoma: a retrospective analysis of the Italian retinoblastoma registryOncogene200625385350535716936757
   PubMed Web of Science ®Google Scholar
• AbramsonDHFrankCMSecond nonocular tumors in survivors of bilateral retinoblastoma: a possible age effect on radiation-related riskOphthalmology199810545735799544627
   PubMed Web of Science ®Google Scholar
• MollACImhofSMSchouten-Van MeeterenAYKuikDJHofmanPBoersMSecond primary tumors in hereditary retinoblastoma: a register-based study, 1945–1997. Is there an age effect on radiation-related risk?Ophthalmology200110861109111411382638
   PubMed Web of Science ®Google Scholar
• Office for National StatisticsCancer Statistics: Registrations Registrations of Cancer Diagnosed in 2005, EnglandLondonHMSO2008 MB1 No. 36
   Google Scholar
• MacCarthyABayneAMDraperGJNon-ocular tumours following retinoblastoma in Great Britain 1951 to 2004Br J Ophthalmol20099391159116219704040
   PubMed Web of Science ®Google Scholar
• GombosDSHungerfordJAbramsonDHSecondary acute myelogenous leukemia in patients with retinoblastoma: is chemotherapy a factor?Ophthalmology200711471378138317613328
   PubMed Web of Science ®Google Scholar
• SmithMARubinsteinLUngerleiderRSTherapy-related acute myeloid leukemia following treatment with epipodophyllotoxins: estimating the risksMed Pediatr Oncol199423286988202047
   PubMedGoogle Scholar
• SmithMAMcCaffreyRPKarpJEThe secondary leukemias: challenges and research directionsJ Natl Cancer Inst19968874074188618232
   PubMedGoogle Scholar
• PuiCHRibeiroRCHancockMLAcute myeloid leukemia in children treated with epipodophyllotoxins for acute lymphoblastic leukemiaN Engl J Med199132524168216871944468
   PubMed Web of Science ®Google Scholar
• SmithMARubinsteinLAndersonJRSecondary leukemia or myelodysplastic syndrome after treatment with epipodophyllotoxinsJ Clin Oncol199917256957710080601
   PubMed Web of Science ®Google Scholar
• SauerbreyAStammlerGZintlFVolmMExpression of the retinoblastoma tumor suppressor gene (RBrb-1) in acute leukemiaLeuk Lymphoma1998283–42752839517499
   PubMed Web of Science ®Google Scholar
• La StarzaRWlodarskaIAventinAMolecular delineation of 13q deletion boundaries in 20 patients with myeloid malignanciesBlood19989112312379414289
   PubMed Web of Science ®Google Scholar
• AhujaHGJatPSFotiABar-EliMClineMJAbnormalities of the retinoblastoma gene in the pathogenesis of acute leukemiaBlood19917812325932681683797
   PubMed Web of Science ®Google Scholar
• JamalRGaleREShaunNThomasBWheatleyKLinchDCThe retinoblastoma gene (rb1) in acute myeloid leukaemia: analysis of gene rearrangements, protein expression and comparison of diseases outcomeBr J Haematol19969423423518759895
   PubMed Web of Science ®Google Scholar
• Linn MurphreeAIntraocular retinoblastoma: the case for a new group classifi cationOphthalmol Clin North Am2005181415315763190
   PubMedGoogle Scholar
• EllsworthRMThe practical management of retinoblastomaTrans Am Ophthalmol Soc1969674625345381307
   PubMedGoogle Scholar
• ShieldsCLMashayekhiADemirciHMeadowsATShieldsJAPractical approach to management of retinoblastomaArch Ophthalmol2004122572973515136321
   PubMedGoogle Scholar
• ShieldsCLShieldsJABasic understanding of current classification and management of retinoblastomaCurr Opin Ophthalmol200617322823416794434
   PubMed Web of Science ®Google Scholar
• DenoixPFEnquete permanent dans les centres anticancereaux [Permanent investigation in the anti- cancer centers]Bull Inst Nat Hyg194617075 French
   Google Scholar
• EdgeSBByrdDRComptonCCAJCC Cancer Staging Manual7th edNew YorkSpringer2010561568
   Google Scholar
• MallipatnaCADimarasHHonEGallieBLPublished international classification of retinoblastoma (ICRB) definitions contain inconsistencies: an analysis of impactEvidence Based Ophthalmol200910183185
   Google Scholar
• NovetskyDEAbramsonDHKimJWDunkelIJPublished international classification of retinoblastoma (ICRB) definitions contain inconsistencies – an analysis of impactOphthalmic Genet2009301404419172510
   PubMed Web of Science ®Google Scholar
• DimarasHKimaniKDimbaEARetinoblastomaLancet201237998241436144622414599
   PubMed Web of Science ®Google Scholar
• FingerPHarbourJMurphreeAChapter 52: retinoblastomaEdgeSBByrdDRComptonCCFritzAGGreeneFLTrottiAAJCC Cancer Staging Manual7th edBerlinSpringer Science and Business Media2010561568
   Google Scholar
• ShieldsCLKalikiSRojanapornDAl-DahmashSBianciottoCGShieldsJAIntravenous and intra-arterial chemotherapy for retinoblastoma: what have we learnedCurr Opin Ophthalmol201223320220922450222
   PubMed Web of Science ®Google Scholar
• ShieldsCLShieldsJARetinoblastoma management: advances in enucleation, intravenous chemoreduction, and intra-arterial chemotherapyCurr Opin Ophthalmol201021320321220224400
   PubMed Web of Science ®Google Scholar
• ChawlaBJainAAzadRConservative treatment modalities in retinoblastomaIndian J Ophthalmol201361947948524104705
   PubMed Web of Science ®Google Scholar
• ShieldsCLFulcoEMAriasJDRetinoblastoma frontiers with intravenous, intra-arterial, periocular, and intravitreal chemotherapyEye (Lond)201327225326422995941
   PubMed Web of Science ®Google Scholar
• ZhaoJDimarasHMasseyCPre-enucleation chemotherapy for eyes severely affected by retinoblastoma masks risk of tumor extension and increases death from metastasisJ Clin Oncol201129784585121282531
   PubMed Web of Science ®Google Scholar
• SchiedlerVDubovySRMurrayTGSnare technique for enucleation of eyes with advanced retinoblastomaArch Ophthalmol2007125568068317502508
   PubMedGoogle Scholar
• ChanHSGallieBLMunierFLBeck PopovicMChemotherapy for retinoblastomaOphthalmol Clin North Am2005181556315763191
   PubMedGoogle Scholar
• TsuiJYDalgardCVan QuillKRSubconjunctival topotecan in fibrin sealant in the treatment of transgenic murine retinoblastomaInvest Ophthalmol Vis Sci200849249049618234990
   PubMed Web of Science ®Google Scholar
• AugsburgerJJFaulknerCBIndirect ophthalmoscope argon laser treatment of retinoblastomaOphthalmic Surg19922395915931480365
   PubMedGoogle Scholar
• ShieldsJAShieldsCLTreatment of retinoblastoma with cryotherapyTrans Pa Acad Ophthalmol Otolaryngol1990429779802084997
   PubMedGoogle Scholar
• ChanMPYHungerfordJLKingstonJEPlowmanPNSalvage external beam radiotherapy after failed primary chemotherapy for bilateral retinoblastoma: rate of eye and vision preservationBr J Ophthalmol200993789189419329423
   PubMed Web of Science ®Google Scholar
• ShieldsCLShieldsJACaterJOthmaneISinghADMicailyBPlaque radiotherapy for retinoblastoma: long-term tumor control and treatment complications in 208 tumorsOphthalmology2001108112116212111713089
   PubMed Web of Science ®Google Scholar
• KingstonJEHungerfordJLMadreperlaSAPlowmanPNResults of combined chemotherapy and radiotherapy for advanced intraocular retinoblastomaArch Ophthalmol199611411133913438906024
   PubMedGoogle Scholar
• ScheflerACCicciarelliNFeuerWToledanoSMurrayTGMacular retinoblastoma: evaluation of tumor control, local complications, and visual outcomes for eyes treated with chemotherapy and repetitive foveal laser ablationOphthalmology2007114116216917070578
   PubMed Web of Science ®Google Scholar
• GallieBLBudningADeBoerGChemotherapy with focal therapy can cure intraocular retinoblastoma without radiotherapyArch Ophthalmol199611411132113288906022
   PubMedGoogle Scholar
• MurphreeALVillablancaJGDeeganWF3rdChemotherapy plus local treatment in the management of intraocular retinoblastomaArch Ophthalmol199611411134813568906025
   PubMedGoogle Scholar
• ShieldsCLDe PotterPHimelsteinBPShieldsJAMeadowsATMarisJMChemoreduction in the initial management of intraocular retinoblastomaArch Ophthalmol199611411133013388906023
   PubMedGoogle Scholar
• ShieldsCLHonavarSGMeadowsATChemoreduction plus focal therapy for retinoblastoma: factors predictive of need for treatment with external beam radiotherapy or enucleationAm J Ophthalmol2002133565766411992863
   PubMed Web of Science ®Google Scholar
• LeaheyAMSystemic chemotherapy: a pediatric oncology perspectiveRamasubramanianAShieldsCLRetinoblastomaNew Delhi, IndiaJaypee Brothers Medical Publishers20128185
   Google Scholar
• WilsonMWRodriguez-GalindoCHaikBGMoshfeghiDMMerchantTEPrattCBMultiagent chemotherapy as neoadjuvant treatment for multifocal intraocular retinoblastomaOphthalmology2001108112106211511713087
   PubMed Web of Science ®Google Scholar
• ShieldsCLMashayekhiAAuAKThe international classification of retinoblastoma predicts chemoreduction successOphthalmology2006113122276228016996605
   PubMed Web of Science ®Google Scholar
• BerryJLJubranRKimJWLong-term outcomes of Group D eyes in bilateral retinoblastoma patients treated with chemoreduction and low-dose IMRT salvagePediatr Blood Cancer201360468869322997170
   PubMed Web of Science ®Google Scholar
• LambertMPShieldsCLMeadowsATA retrospective review of hearing in children with retinoblastoma treated with carboplatin-based chemotherapyPediatr Blood Cancer200850222322617278120
   PubMed Web of Science ®Google Scholar
• LeaheyAA cautionary tale: dosing chemotherapy in infants with retinoblastomaJ Clin Oncol201230101023102422370322
   PubMed Web of Science ®Google Scholar
• BenzMSScottIUMurrayTGKramerDToledanoSComplications of systemic chemotherapy as treatment of retinoblastomaArch Ophthalmol2000118457757810766148
   PubMedGoogle Scholar
• TurakaKShieldsCLLeaheyAMeadowsATSecond malignant neoplasms following chemoreduction with carboplatin, etoposide, and vincristine in 245 patients with intraocular retinoblastomaPediatr Blood Cancer201259112112521826785
   PubMed Web of Science ®Google Scholar
• ShieldsCLShieldsJAMeadowsATChemoreduction for retinoblastoma may prevent trilateral retinoblastoma [letter]J Clin Oncol200018123623710623718
   PubMed Web of Science ®Google Scholar
• ShieldsCLMeadowsATShieldsJACarvalhoCSmithAFChemoreduction for retinoblastoma may prevent intracranial neuroblastic malignancy (trilateral retinoblastoma)Arch Ophthalmol200111991269127211545631
   PubMedGoogle Scholar
• RamasubramanianAKytastyCMeadowsATShieldsJALeaheyAShieldsCLIncidence of pineal gland cyst and pineoblastoma in children with retinoblastoma during the chemoreduction eraAm J Ophthalmol2013156482582923876864
   PubMed Web of Science ®Google Scholar
• DemirciHShieldsCLMeadowsATShieldsJALong-term visual outcome following chemoreduction for retinoblastomaArch Ophthalmol2005123111525153016286614
   PubMedGoogle Scholar
• KivelaTAlive with good vision: the ultimate goal in managing retinoblastomaClin Exper Ophthalmol2012407655656
   Web of Science ®Google Scholar
• YamaneTKanekoAMohriMThe technique of ophthalmic arterial infusion therapy for patients with intraocular retinoblastomaInt J Clin Oncol200492697315108036
   PubMedGoogle Scholar
• SuzukiSKanekoAManagement of intraocular retinoblastoma and ocular prognosisInt J Clin Oncol2004911615162819
   PubMedGoogle Scholar
• AbramsonDHDunkelIJBrodieSEKimJWGobinYPA phase I/II study of direct intraarterial (ophthalmic artery) chemotherapy with melphalan for intraocular retinoblastoma: initial resultsOphthalmology200811581398140418342944
   PubMed Web of Science ®Google Scholar
• MarrBPBrodieSEDunkelIJGobinYPAbramsonDHThree-drug intra-arterial chemotherapy using simultaneous carboplatin, topotecan and melphalan for intraocular retinoblastoma: preliminary resultsBr J Ophthalmol201296101300130322863945
   PubMed Web of Science ®Google Scholar
• GhassemiFGhanaatiHKarkhanehRBoujabadiLTabatabaieSZRajabiMTOutcome of retinoblastoma following limited sessions of intra-arterial chemotherapy in IranIran J Radiol2014113e1695825763076
   PubMed Web of Science ®Google Scholar
• ThampiSHettsSWCookeDLSuperselective intra-arterial melphalan therapy for newly diagnosed and refractory retinoblastoma: results from a single institutionClin Ophthalmol2013798198923818751
   PubMedGoogle Scholar
• SchaiquevichPCecilianoAMillanNIntra-arterial chemotherapy is more effective than sequential periocular and intravenous chemotherapy as salvage treatment for relapsed retinoblastomaPediatr Blood Cancer201360576677023024125
   PubMed Web of Science ®Google Scholar
• FrancisJHGobinYPDunkelIJCarboplatin +/− topotecan ophthalmic artery chemosurgery for intraocular retinoblastomaPLoS One201388e7244123991112
   PubMed Web of Science ®Google Scholar
• GobinYPDunkelIJMarrBPBrodieSEAbramsonDHIntra-arterial chemotherapy for the management of retinoblastoma: four-year experienceArch Ophthalmol2011129673273721320950
   PubMed Web of Science ®Google Scholar
• ShieldsCLManjandavidaFPLallySEIntra-arterial chemotherapy for retinoblastoma in 70 eyes: outcomes based on the international classification of retinoblastomaOphthalmology201412171453146024656794
   PubMed Web of Science ®Google Scholar
• SaylorsRL3rdStewartCFZamboniWCPhase I study of topotecan in combination with cyclophosphamide in pediatric patients with malignant solid tumors: a Pediatric Oncology Group StudyJ Clin Oncol19981639459529508177
   PubMed Web of Science ®Google Scholar
• TaichPCecilianoABuitragoEClinical pharmacokinetics of intraarterial melphalan and topotecan combination in patients with retinoblastomaOphthalmology2014121488989724359624
   PubMed Web of Science ®Google Scholar
• SchaiquevichPBuitragoECecilianoAPharmacokinetic analysis of topotecan after superselective ophthalmic artery infusion and periocular administration in a porcine modelRetina201232238739521878842
   PubMed Web of Science ®Google Scholar
• PaliouraSGobinYPBrodieSEMarrBPDunkelIJAbramsonDHOphthalmic artery chemosurgery for the management of retinoblastoma in eyes with extensive (>50%) retinal detachmentPediatr Blood Cancer201259585986422492689
   PubMed Web of Science ®Google Scholar
• ShieldsCLBianciottoCGJabbourPIntra-arterial chemotherapy for retinoblastoma: report No. 2, treatment complicationsArch Ophthalmol2011129111407141521670326
   PubMedGoogle Scholar
• MunierFLBeck-PopovicMBBalmerAGaillardMCBoveyEBinaghiSOccurrence of sectoral choroidal occlusive vasculopathy and retinal arteriolar embolization after superselective ophthalmic artery chemotherapy for advanced intraocular retinoblastomaRetina201131356657321273941
   PubMed Web of Science ®Google Scholar
• ShieldsCLLallySELeaheyAMJabbourPMCaywoodEHSchwendemanRShieldsJATargeted retinoblastoma management: when to use intravenous, intra-arterial, periocular, and intravitreal chemotherapyCurr Opin Ophthalmol201425537438525014750
   PubMed Web of Science ®Google Scholar
• SuesskindDSchraderMFoersterMHErnemannUAisenbreySCataract formation: a possible complication of intra-arterial chemotherapy for retinoblastomaEur J Ophthalmol201424344945324242220
   PubMed Web of Science ®Google Scholar
• MuenWJKingstonJERobertsonFBrewSSagooMSReddyMAEfficacy and complications of super-selective intra-ophthalmic artery melphalan for the treatment of refractory retinoblastomaOphthalmology2012119361161622197434
   PubMed Web of Science ®Google Scholar
• SariciAKizilkilicOCelkanTGodeSBlue toe syndrome as a complication of intra-arterial chemotherapy for retinoblastomaJAMA Ophthalmol2013131680180223764710
   PubMed Web of Science ®Google Scholar
• PhillipsTJMcGuirkSPChahalHKAutonomic cardiorespiratory reflex reactions and super selective ophthalmic arterial chemotherapy for retinoblastomaPaediatr Anaesth2013231094094523668238
   PubMed Web of Science ®Google Scholar
• TsimpidaMThompsonDALiasisAVisual outcomes following intraophthalmic artery melphalan for patients with refractory retinoblastoma and age appropriate visionBr J Ophthalmol201397111464147024037611
   PubMed Web of Science ®Google Scholar
• MendelsohnMEAbramsonDHMaddenTTongWTranHTDunkelIJIntraocular concentrations of chemotherapy following systemic or local administrationArch Ophthalmol19981169120912129747681
   PubMedGoogle Scholar
• HaydenBCJockovichMEMurrayTGPharmacokinetics of systemic versus focal carboplatin chemotherapy in the rabbit eye: possible implication in the treatment of retinoblastomaInvest Ophthalmol Vis Sci200445103644364915452072
   PubMed Web of Science ®Google Scholar
• AbramsonDHFrankCMDunkelIJA phase I/II study of subconjunctival carboplatin for intraocular retinoblastomaOphthalmology1999106101947195010519590
   PubMed Web of Science ®Google Scholar
• MallipatnaACDimarasHChanHSPeriocular topotecan for intraocular retinoblastomaArch Ophthalmol2011129673874521670340
   PubMedGoogle Scholar
• CarcabosoAMChiappettaDAOpezzoJAEpiscleral implants for topotecan delivery to the posterior segment of the eyeInvest Ophthalmol Vis Sci20105142126213419834044
   PubMed Web of Science ®Google Scholar
• MulvihillABudningAJayVOcular motility changes after subtenon carboplatin chemotherapy for retinoblastomaArch Ophthalmol200312181120112412912689
   PubMedGoogle Scholar
• YousefYAHallidayWChanHSHéonEGallieBLDimarasHNo ocular motility complications after subtenon topotecan with fibrin sealant for retinoblastomaCan J Ophthalmol201348652452824314416
   PubMed Web of Science ®Google Scholar
• EricsonLAKalbergBRosengrenBHTrials of intravitreal injections of chemotherapeutic agents in rabbitsActa Ophthalmol19644247217264966433
   PubMed Web of Science ®Google Scholar
• KivelaTEskelinSPaloheimoMIntravitreal methotrexate for retinoblastomaOphthalmology2011118816891689.e1.e621813093
   PubMed Web of Science ®Google Scholar
• InomataMKanekoAChemosensitivity profiles of primary and cultured retinoblastoma cells in a human tumor clonogenic assayJpn J Cancer Res19877888588683115934
   PubMedGoogle Scholar
• SuzukiSAiharaYFujiwaraMSanoSKanekoAIntravitreal injection of melphalan for intraocular retinoblastomaJpn J Ophthalmol Epub2015313
   Web of Science ®Google Scholar
• MunierFLGaillardMCBalmerAIntravitreal chemotherapy for vitreous disease in retinoblastoma revisited: from prohibition to conditional indicationsBr J Ophthalmol20129681078108322694968
   PubMed Web of Science ®Google Scholar
• GhassemiFShieldsCLIntravitreal melphalan for refractory or recurrent vitreous seeding from retinoblastomaArch Ophthalmol2012130101268127123044940
   PubMedGoogle Scholar
• GhassemiFAmoliFAPathological findings in enucleated eyes after intravitreal melphalan injectionInt Ophthalmol201434353354024043335
   PubMed Web of Science ®Google Scholar
• SmithSJSmithBDEvaluating the risk of extraocular tumour spread following intravitreal injection therapy for retinoblastoma: a systematic reviewBr J Ophthalmol201397101231123623740960
   PubMed Web of Science ®Google Scholar
• ShieldsCLManjandavidaFPArepalliSKalikiSLallySEShieldsJAIntravitreal melphalan for persistent or recurrent retinoblastoma vitreous seeds: preliminary resultsJAMA Ophthalmol2014132331932524407202
   PubMed Web of Science ®Google Scholar
• GhassemiFShieldsCLGhadimiHKhodabandehARoohipoorRCombined intravitreal melphalan and topotecan for refractory or recurrent vitreous seeding from retinoblastomaJAMA Ophthalmol2014132893694124789622
   PubMed Web of Science ®Google Scholar
• SmithSJSmithBDMohneyBGOcular side effects following intravitreal injection therapy for retinoblastoma: a systematic reviewBr J Ophthalmol201498329229724187047
   PubMed Web of Science ®Google Scholar
• PhiliponnetAGrangeJDBaggettoLGApplication of gene therapy to oncologic ophthalmologyJ Fr Ophtalmol201437215516524503203
   PubMed Web of Science ®Google Scholar